Ingersoll Rand Inc.'s Stock Analysis

Ingersoll Rand Reports Record Orders and Revenue for Q2 2025

Ingersoll Rand, Inc. reported record financial results for the second quarter of 2025, with orders reaching $1,940 million, an increase of 8% compared to the same period in 2024. Revenues also grew by 5% to $1,888 million, while adjusted EBITDA rose by 3% to $509 million, representing a margin of 27.0%. The company recorded a net loss of $115 million, or $0.29 per share, but reported adjusted net income of $325 million, or $0.80 per share. Operating cash flow stood at $246 million, with free cash flow of $210 million, contributing to a liquidity position of $3.9 billion as of June 30, 2025, which includes $1.3 billion in cash and $2.6 billion in available credit facilities.

Ingersoll Rand's Industrial Technologies and Services segment saw orders of $1,561 million, up 7%, while revenue was $1,492 million, reflecting a 2% increase. The Precision and Science Technologies segment reported orders of $379 million, a 13% increase, and revenues of $396 million, up 17%. The company raised its guidance for full-year 2025 revenue, adjusted EBITDA, and adjusted EPS, while also investing $47 million in mergers and acquisitions during the quarter. Shareholder returns included approximately $508 million through share repurchases and dividends.

Jul 31, 2025 16:33:22

Ingersoll Rand Appoints Aurobind Satpathy to Board of Directors

Ingersoll Rand Inc. has appointed Aurobind Satpathy as a new director on its Board, effective July 15, 2025. Satpathy, a senior partner at McKinsey & Company, brings nearly 30 years of experience in leading significant mergers and guiding companies through transitions. He will also serve on the Nominating and Corporate Governance Committee and the Sustainability Committee, and is recognized as an independent director under New York Stock Exchange standards.

The Board has resized to nine directors with Satpathy's appointment, which reflects the company’s commitment to a dynamic governance structure. His compensation as a non-employee director includes a prorated amount based on the company's compensation policy and an equity award of restricted stock units to be granted on August 6, 2025. The announcement emphasizes Ingersoll Rand's focus on innovation and operational excellence.

Jul 15, 2025 08:37:22

Ingersoll Rand Reports Record Orders and Increased Share Repurchase Program

Ingersoll Rand Inc. announced its first quarter 2025 results, highlighting record orders of $1.882 billion, a 10% increase from the previous year, and revenues of $1.717 billion, up 3%. The company reported a net income of $187 million, or $0.46 per share. Free cash flow rose significantly to $223 million, marking a 124% increase compared to the same period last year. The company also maintained strong liquidity with $4.2 billion available, including $1.6 billion in cash and undrawn credit facilities.

The Board of Directors has approved a $1 billion increase to the share repurchase program, allowing for up to $750 million in share buybacks by the end of 2025. Ingersoll Rand remains focused on strategic acquisitions and has recently completed two acquisitions in the chillers and gas generation sectors. The company’s financial position is strong, with a net debt to adjusted EBITDA ratio of 1.6x, reflecting its ongoing commitment to shareholder value and capital allocation strategies.

May 01, 2025 16:34:04

Ingersoll Rand Appoints New Board Member Amid Strategic Changes

Ingersoll Rand Inc. has appointed Michelle Swanenburg to its Board of Directors, effective immediately. Swanenburg, who is currently the head of Human Resources at T. Rowe Price, brings over twenty years of experience in HR leadership and is expected to contribute to the company's focus on enhancing workforce experiences. Her involvement in various committees at T. Rowe Price and previous roles, including at Oaktree Capital Management, adds to her qualifications for this position.

The announcement emphasizes the importance of human capital management and corporate governance for Ingersoll Rand, as highlighted by CEO Vicente Reynal. However, the press release includes a caution about potential risks and uncertainties that could affect the company's operations and financial performance, such as geopolitical tensions and economic conditions, which may impact future results.

Apr 03, 2025 08:42:01

Ingersoll Rand Reports $1.8 Billion in Orders for Q4 2024

Ingersoll Rand announced record results for the fourth quarter and full year of 2024, with reported orders reaching $1.8 billion, an 8% increase, and revenues of $1.9 billion, up 4%. The company reported a net income of $230 million, translating to earnings of $0.57 per share. Notably, adjusted net income was $344 million, or $0.84 per share, and adjusted EBITDA grew by 6% to $532 million, reflecting a margin improvement. The company maintained strong liquidity with $4.1 billion available, including $1.5 billion in cash, and generated a free cash flow of $491 million, indicating robust operational performance for the year.

However, the Precision and Science Technologies segment faced challenges, with reported orders increasing by only 29% but down 1% organically, and revenues rising by 24% but down 5% organically. The segment's adjusted EBITDA margin declined by 250 basis points, primarily due to lower volumes in the aerospace and defense business. Additionally, operating cash flow decreased slightly compared to the previous year, highlighting potential pressures in certain areas of the business. The company’s net debt to adjusted EBITDA leverage also increased to 1.6x, attributed to recent acquisitions, raising concerns about future financial flexibility.

Feb 13, 2025 16:40:09

Ingersoll Rand Reports $1.86 Billion Revenue in Q3 2024

Ingersoll Rand reported record third quarter results for 2024, with revenues reaching $1.86 billion, marking a 7% increase from the previous year. The company also saw a significant rise in adjusted earnings per share (EPS), which grew to $0.84, and an adjusted EBITDA of $533 million, reflecting a 15% year-over-year increase. Additionally, third quarter orders totaled $1.8 billion, up 10%, and free cash flow was reported at $374 million, maintaining a free cash flow margin of 20%. The company’s liquidity stood at $4 billion, bolstered by cash on hand and undrawn credit facilities, indicating a strong financial position overall.

Conversely, the Precision and Science Technologies segment experienced a decline in organic revenue, with reported revenues down 3%, despite a 30% increase in orders. The segment's adjusted EBITDA margin also fell by 30 basis points, attributed largely to its Life Sciences businesses. Furthermore, the company's net debt to adjusted EBITDA ratio increased to 1.7x, which was partly a result of the acquisition of ILC Dover earlier in the year. While the overall performance was positive, these challenges in specific segments and the rising leverage ratio could raise concerns among investors.

Oct 31, 2024 16:40:14

Ingersoll Rand Achieves Record Revenue and Raises Guidance

Ingersoll Rand reported record revenue and earnings for Q2 2024, driven by strong operational execution. The company raised its full-year guidance for revenue, EBITDA, and earnings per share, reflecting confidence in continued growth despite some market challenges. It also maintained a strong financial position with significant liquidity and completed several acquisitions to enhance its portfolio.

Jul 31, 2024 16:55:42

Ingersoll Rand Reports Record First Quarter 2024 Performance and Raises Guidance

Ingersoll Rand achieved record first quarter revenue, Adjusted EBITDA, and Adjusted EPS, driven by strong operational execution. Despite a decrease in orders, the company's performance remains robust. Ingersoll Rand raised its 2024 guidance for Adjusted EBITDA and Adjusted EPS, reflecting confidence in continued commercial success. The company also highlighted its solid financial position, with ample liquidity and improved debt leverage. In addition, Ingersoll Rand expanded its share repurchase program and invested in strategic acquisitions.

May 02, 2024 16:32:33

Ingersoll Rand to Acquire ILC Dover, Expanding Life Sciences Presence

Ingersoll Rand's acquisition of ILC Dover for $2.325 billion aims to boost their life sciences offerings, adding innovative solutions and expanding their market by $10 billion. With a focus on biopharma and medical devices, the deal is expected to be immediately accretive, offering growth opportunities and enhancing customer value. The acquisition is anticipated to close in Q2 2024, driving Ingersoll Rand's revenue and margin rates up, supported by a strong historical revenue growth trajectory and synergistic opportunities between the two companies.

Mar 25, 2024 07:27:26

Ingersoll Rand Reports Record Fourth Quarter and Full Year 2023 Results

Ingersoll Rand reported strong fourth quarter and full year 2023 results with increased orders, revenues, net income, and cash flow. The company's 2024 outlook indicates expected revenue growth of 5-7%, with positive projections for adjusted EBITDA and EPS. The CEO highlighted the company's performance, attributing it to operational excellence and pivoting to high-growth sustainable markets. Ingersoll Rand also emphasized employee satisfaction and sustainability efforts. The Industrial Technologies and Services segment showed significant growth, while Precision and Science Technologies faced challenges in certain markets.

Feb 15, 2024 16:41:57